Report Highlights
The global market for animal therapeutics and diagnostics is estimated to increase from $61.0 billion in 2023 to reach $81.2 billion by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.
Report Includes
- 56 data tables and 143 additional tables
- An overview of the global market for animal therapeutics and diagnostics
- Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
- Assessment of market drivers, opportunities, and restraints, and current trends and technological advances
- Evaluation of the market with a focus of global production of animal healthcare products, vaccines, feed additives, therapeutic and diagnostic drugs
- Analyses of the market shares of the leading suppliers of animal vaccines and therapeutic drugs, the competitive landscape, market positioning, revenue sales and product segments
- Discussion of the role of major providers of vaccines and companion animal products approved for a wide variety of indications, and emerging technologies in the market.
- Analyses of ESG trends and patents granted for animal health products
- Profiles of the leading companies, including Boehringer Ingelheim, DSM Nutritional Products, Merck & Co. Inc., Phibro Animal Health Corp., Virbac S.A., and Zoetis Services LLC
Report Scope
The report’s scope includes an overview of the global market for animal therapeutics and diagnostics along with an analysis of global market trends; the report uses 2022 as the base year and forecasts 2023 the compound annual growth rate (CAGR) for 2023 to 2028.
The report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends, and statistics by key geographical regions such as the United States, European countries, and Brazil, Japan, and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives, and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers, and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||
| Base year market size | $57.6 billion | ||||||||||||
| Market size forecast | $81.2 billion | ||||||||||||
| Growth rate | CAGR of 5.9% for the forecast period of 2023-2028 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | Product Type, Animal Group, and Geographical Region | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of World | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
||||||||||||
Frequently Asked Questions (FAQs)
- Rising trend of companion pet ownership
- Growing incidence and prevalence of animal diseases
- The increasing variety of zoonotic diseases
- Growing animal health insurance
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global animal therapeutics and diagnostics market should grow from $49.9 billion in 2019 to $66.5 billion by 2024 with a compound annual growth rate (CAGR) of 5.9% for the period of 2019-2024.
Report Includes
- 64 data tables and 109 additional tables
- Brief overview of the global market for animal therapeutics and diagnostics within the industry
- Analyses of the global market trends, with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Assessment of factors driving the industry's growth, current trends, market opportunities and restraints, and technological advancements that will shape and influence the future marketplace
- Evaluation of the market size corresponding to total production of animal healthcare products, vaccines, feed additives, therapeutic and diagnostic drugs; their growth forecasts and industry trends
- Market share analysis of the leading animal vaccines and therapeutic drug suppliers; their key Competitive landscape, market positioning, revenue sales, and product segments
- Patent study and analysis covering significant allotments of the U.S. patents granted on animal health products
- Discussion on the role of major vaccine providers and companion animal products approved for a wide variety of indications, including adenovirus type 2, coronavirus, parainfluenza, parvovirus, melanoma (therapeutic vaccine), West Nile virus, and canine respiratory disease etc.
- Detailed company profiles of the market leading participants. Major players included BASF Animal Nutrition, Bayer Animal Health GmbH, DSM Nutritional Products Ltd., Evonik Industries AG, Merck Animal Health and Mosaic Co.
Report Highlights
The global market for animal therapeutics and diagnostics totaled nearly $40.1 billion in 2016 and should total $47.9 billion in 2021, registering a compound annual growth rate (CAGR) of 3.6% for the period 2016-2021.
Report Includes
- An overview of the global markets for animal therapeutics and diagnostics
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Details about products currently in the market
- Analysis of the competitive environment
- A look at keys to market success including identifying the next growth segment, developing the right product candidates, and being the first to market
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
- Profiles of major players in the industry
Report Highlights
The global market for animal therapeutics and diagnostics totaled $37.8 billion in 2014 and is expected to reach about $46.5 billion in 2019, registering a compound annual growth rate (CAGR) of 4.2% for the period 2014-2019.
Report Includes
- An overview of the global markets for animal therapeutics and diagnostics.
- Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
- Details about products currently in the market.
- Analysis of the competitive environment.
- A look at keys to market success including identifying the next growth segment, developing the right product candidates, and being the first to market.
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities.
Report Highlights
The total market for animal therapeutics and diagnostics was $30 billion in 2011, up from $25 billion in 2008. By 2016, this market is likely to exceed $42 billion, with a five-year compound annual growth rate (CAGR) of 7.2% from 2011 through 2016.
Report Highlights
- The global market for animal therapeutics and diagnostics is expected to be worth $24.1 billion in 2008, up from $22.3 billion in 2007. This should increase to $33.0 billion in 2013, a compound annual growth rate (CAGR) of 6.5%.
- The animal therapeutics segment dominates the market, generating $21.8 billion in 2007 and an estimated $23.6 billion in 2008 and $32.4 billion in 2012, a CAGR of 6.6%.
- Diagnostics for animals were worth $474 million in 2007. This should increase to $498 million in 2008 and $624 million in 2013, for a CAGR of 4.6%.
Report Highlights
-
The total worldwide market for animal therapeutics and diagnostics was estimated at more than $15.6 billion in 2003 and by 2008 is likely to reach $19.6 billion, at an average annual growth rate (AAGR) of 4.7%.
-
Animal therapeutics, e.g., vaccines, pharmaceuticals, and feed additives, are valued at $15.1 billion, and rising at an AAGR of 4.7%.
-
Pharmaceuticals account for the largest percentage of revenues at nearly 54%.
-
Feed additives are the second largest market segment due to demand from the food animal producer segment.
-
Diagnostic products account for a smaller portion of the market
Related Reports
Global Markets for Vaccine Technologies
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
Global Market for Pain Management Drugs and Devices
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
Commercial Amino Acids
The global amino acids market was $28.6 billion in 2022 and it should reach $38.8 billion by 2028 from $30.1 billion in 2023 at a compound annual growth rate (CAGR) of 5.2% for the forecast period of 2023 to 2028.
Veterinary Vaccines: Global Markets
The global veterinary vaccines market reached $9.1 billion in 2022, should reach $9.6 billion by 2023 and $14.2 billion by 2028 with a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2023-2028.
Recent Reports
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.
Global Cleanroom Technology Market
The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Microelectromechanical Systems (MEMS) in Global Medical Markets
The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More